News

Tue, 09/10/2018
High-ranking Lectures on Immunotherapy and its risks
Muenster. The Department of Neurology Muenster is pleased to announce its Neurology Seminar with guest lecturers Prof. Stephen Reddel and Prof. Helmut Butzkueven. Professor Stephen Reddel’s talk will focus on immunosuppression safety. Reddel is a staff specialist neurologist at Concord Repatriation & General Hospital Sydney, consultant neurologist at the Brain & Mind Centre, University of […]...more
Tue, 09/10/2018
Munich Cluster for Systems Neurology (SyNergy) will be funded
Munich. The Cluster for Systems Neurology (SyNergy) by LMU and TUM will receive funding from 2019 on. Currently SFB PIs Prof. Reinhard Hohlfeld, Prof. Martin Kerschensteiner, Prof. Mikael Simons are also PIs of SyNergy projects....more
Fri, 31/08/2018
Women in Science Network Conference “Decision Making in Infection and Immunity”
The female scientists invite you to the Women-in-Science Network Conference Münster 2018, co-funded by the SFB TR-128. This conference taking place on November 27 and 28 has two main goals: (1) to present and discuss top-level scientific contributions and (2) to increase visibility, encourage leadership, and provide a strong community for women in science. The […]...more


Thu, 09/11/2017 | Elisabeth Schuh received SEED funding

Munich. SFB 128 researcher Elisabeth Schuh, MD, has been honoured by a young scientist’s studentship within the KKNMS SEED program. In her project „The role of the NLRP3 inflammasome in multiple sclerosis and experimental autoimmune encephalomyelitis“, Dr. Schuh analyses the influence of the NLRP3in MS. NLRP is a cytosolic protein complex in monocytes, macrophages and neutrophil granolucytes that regulated the production of inflammatory cytokines of the interleukin-1 family. In her project, Dr. Schuh wants to identify the population of myeloid cells involved in MS pathogenesis, with the aim of finding new pathways for therapeutic intervention that prevent autoimmune tissue damage.
The SEED program addresses scientists younger than 32 years who have not yet completed their medical training. The maximum funding is 32.000 € or 75 percent of the project’s budget. The remaining 25% have to be paid by the stipend’s employee.